Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in the Gambia

Virology Journal

Volumn 5, Issue , 2008, Pages

  Mendy, Maimuna E ^a   McConkey, Samuel J ^a,b   Sande Van Der, Marianne A B ^a,c   Crozier, Sarah ^a,d   Kaye, Steve ^a,e   Jeffries, David ^a   Hall, Andrew J ^f   Whittle, Hilton C ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GAMBIA; HEALTH STATUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; VIRUS CARRIER; VIRUS LOAD; AGE; BLOOD; HETEROZYGOTE; INFANT; LONGITUDINAL STUDY; PRESCHOOL CHILD; VIROLOGY;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GAMBIA; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; VIRAL LOAD;

EID: 43149102738     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-49     Document Type: Article

References (33)

1. Hepatitis B virus infection. WM Lee, N Engl J Med 1997 337 1733 1745 10.1056/NEJM199712113372406 9392700
2. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. JP Villeneuve M Desrochers C Infante-Rivard B Willems G Raymond M Bourcier J Cote G Richer, Gastroenterology 1994 106 1000 1005 8143967
3. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. M Manno C Camma F Schepis F Bassi R Gelmini F Giannini F Miselli A Grottola I Ferretti C Vecchi M De Palma E Villa, Gastroenterology 2004 127 756 763 10.1053/j.gastro.2004.06.021 15362032
4. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. GD Kirk OA Lesi M Mendy AO Akano O Sam JJ Goedert P Hainaut AJ Hall H Whittle R Montesano, Hepatology 2004 39 211 219 10.1002/hep.20027 14752840
5. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts. K Ikeda Y Arase S Saitoh M Kobayashi T Someya T Hosaka N Akuta Y Suzuki F Suzuki H Sezaki H Kumada A Tanaka H Harada, J Hepatol 2006 44 1089 1097 10.1016/j.jhep.2006.02.008 16618514
6. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. HK Seitz F Stickel, Biol Chem 2006 387 349 360 10.1515/BC.2006.047 16606331
7. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. GD Kirk OA Lesi M Mendy K Szymanska H Whittle JJ Goedert P Hainaut R Montesano, Oncogene 2005 24 5858 5867 10.1038/sj.onc.1208732 16007211
8. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. GD Kirk PC Turner Y Gong OA Lesi M Mendy JJ Goedert AJ Hall H Whittle P Hainaut R Montesano CP Wild, Cancer Epidemiol Biomarkers Prev 2005 14 373 379 10.1158/1055-9965.EPI-04-0161 15734960
9. HBV induced carcinogenesis. D Cougot C Neuveut MA Buendia, J Clin Virol 2005 34 Suppl 1 S75 8 10.1016/S1386-6532(05)80014-9 16461228
10. Hepatitis B: virology, epidemiology, disease, and prevention, and an overview of viral hepatitis. LA Moyer EE Mast, Am J Prev Med 1994 10 Suppl 45 55 7841006
11. Hepatitis B e antigen and the risk of hepatocellular carcinoma. HI Yang SN Lu YF Liaw SL You CA Sun LY Wang CK Hsiao PJ Chen DS Chen CJ Chen, N Engl J Med 2002 347 168 174 10.1056/NEJMoa013215 12124405
12. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. CJ Chen HI Yang J Su CL Jen SL You SN Lu GT Huang UH Iloeje, Jama 2006 295 65 73 10.1001/jama.295.1.65 16391218
13. Hepatitis B virus infection in two Gambian villages. HC Whittle AK Bradley K McLauchlan AB Ajdukiewicz CR Howard AJ Zuckerman IA McGregor, Lancet 1983 1 1203 1206 10.1016/S0140-6736(83)92477-7 6133999
14. Cancer in the Gambia: 1988-97. E Bah DM Parkin AJ Hall AD Jack H Whittle, Br J Cancer 2001 84 1207 1214 10.1054/bjoc.2001.1730 11336472
15. The pattern of childhood hepatitis B infection in two Gambian villages. HC Whittle H Inskip AK Bradley K McLaughlan F Shenton W Lamb J Eccles BA Baker AJ Hall, J Infect Dis 1990 161 1112 1115 2345294
16. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia. ME Mendy S Kaye M van der Sande P Rayco-Solon PA Waight D Shipton D Awi P Snell H Whittle SJ McConkey, Virol J 2006 3 23 16594999 10.1186/1743-422X-3-23
17. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage. ME Mendy M Fortuin AJ Hall AD Jack HC Whittle, Br J Biomed Sci 1999 56 34 38 10492913
18. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. HJ Alter LB Seeff PM Kaplan VJ McAuliffe EC Wright JL Gerin RH Purcell PV Holland HJ Zimmerman, N Engl J Med 1976 295 909 913 967200
19. The e antigen and vertical transmission of hepatitis B surface antigen. RP Beasley C Trepo CE Stevens W Szmuness, Am J Epidemiol 1977 105 94 98 835566
20. Current issues and future directions in treatment. CK Hui GK Lau, Semin Liver Dis 2006 26 192 197 10.1055/s-2006-939757 16673297
21. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages [see comments]. HC Whittle N Maine J Pilkington M Mendy M Fortuin J Bunn L Allison C Howard A Hall, Lancet 1995 345 1089 1092 10.1016/S0140-6736(95)90822-6 7715343
22. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. HC Whittle H Inskip AJ Hall M Mendy R Downes S Hoare, Lancet 1991 337 747 750 10.1016/0140-6736(91)91367-4 1672389
23. Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers. U Dumpis M Mendy A Hill M Thursz A Hall H Whittle P Karayiannis, J Med Virol 2001 65 664 670 10.1002/jmv.2088 11745929
24. HBV infection in The Gambia. HC Whittle K McLauchlan AK Bradley AB Ajdukiewicz CR Howard AJ Zuckerman IA McGregor, Lancet JID - 2985213R 1983 2 733 Whittle, H 10.1016/S0140-6736(83)92266-3
25. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. HC Whittle N Maine J Pilkington M Mendy M Fortuin J Bunn L Allison C Howard A Hall, Lancet 1995 345 1089 1092 10.1016/S0140-6736(95)90822- 6 7715343
26. Long-term protection against carriage of hepatitis B virus after infant vaccination. MA van der Sande P Waight M Mendy P Rayco-Solon P Hutt T Fulford C Doherty SJ McConkey D Jeffries AJ Hall HC Whittle, J Infect Dis 2006 193 1528 1535 10.1086/503433 16652281
27. Seropositivity of hepatitis B e antigen and hepatocellular carcinoma. SL You HI Yang CJ Chen, Ann Med 2004 36 215 224 10.1080/07853890310021580 15181977
28. The etiology of acute viral hepatitis in an endemic area of hepatitis A and B. YF Liaw CM Chu MJ Huang TJ Chen DY Lin, Am J Trop Med Hyg 1983 32 1401 1406 6418018
29. Levamisole therapy in chronic type B hepatitis. Results of a double-blind randomized trial. G Fattovich L Brollo P Pontisso E Pornaro M Rugge A Alberti G Realdi, Gastroenterology 1986 91 692 696 3525317
30. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. CJ Chen LY Wang MW Yu, J Gastroenterol Hepatol 2000 15 Suppl E3 6 10.1046/j.1440-1746.2000.02124.x 10921373
31. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. CK Hui N Leung ST Yuen HY Zhang KW Leung L Lu SK Cheung WM Wong GK Lau, Hepatology 2007 46 395 401 10.1002/hep.21724 17628874
32. Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. MF Schim van der Loeff R Sarge-Njie S Ceesay AA Awasana P Jaye O Sam KO Jaiteh D Cubitt P Milligan HC Whittle, Aids 2003 17 1841 1846 10.1097/00002030-200308150-00014 12891071
33. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. GD Kirk AM Camus-Randon M Mendy JJ Goedert P Merle C Trepo C Brechot P Hainaut R Montesano, J Natl Cancer Inst 2000 92 148 153 10.1093/jnci/92.2.148 10639517